Fracture risk in osteoporosis – when to use anabolic therapy

Learn about the pathophysiology of osteoporosis and therapies available for its treatment across the spectrum of fracture risk.

You will learn:
The pathophysiology of osteoporosis
The therapies available for treatment of osteoporosis across the spectrum of fracture risk
Evidence of the efficacy of anabolic therapy in the high and very high-risk patient
Factors that contribute to a very high risk of fracture.

Talk from NOFSA 2021 Virtual Congress Held on 5-7 August 2021

ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.

To access this module, please register or login: